TSXV/ARCH (TSXV/ARCH)

TSX Venture Exchange: TSXV/ARCH · CAD

CA$0.86

-0.01 (-1.1%)· Recorded snapshot

Market cap	55.9M
Net income (ttm)	-2.8M
EPS (ttm)	-CA$0.04
Volume	7,002
Beta	1.80

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -2.8M
EPS (ttm): -CA$0.04
Market cap: 55.9M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/ARCH indicators

Market & fundamental data

Available fields

132

Groups with data

Currency

CAD

Showing 132 of 132 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2027-01-29
Enterprise value	CAD 58.6M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	September
Industry	Biotechnology
Is primary listing	No
ISIN number	CA03938C1041
Last earnings date	2026-01-29
Last refreshed	2026-10-28
Market cap	CAD 55.9M
Next earnings date	2027-01-29
Price	CAD 0.86
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	tsxv/ARCH
Website	https://www.archbiopartners.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-4.85%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-954.27%
ROA (5Y)	-122.24%
ROCE	62%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Net income growth years	1
Revenue growth	-87%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -2.5M
EPS	CAD -0.04
Financing cash flow	CAD 1.6M
Gross profit	CAD -743,828
Net borrowing	CAD -94,582
Net cash flow	CAD -164,546
Net income	CAD -2.8M
Operating income	CAD -2.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1,098.32
Book value per share	CAD -0.06
Interest coverage	-10.53
Long-term assets	CAD 0
Long-term liabilities	CAD -0
Net cash (debt)	CAD -2.7M
Net cash / market cap	-4.82%
Piotroski F-Score	1
Shareholders' equity	CAD -4M
Tangible book value	CAD -4M
Tangible book value per share	CAD -0.06
Total assets	CAD 57,216
Total cash	CAD 2,914
Total debt	CAD 2.7M
Total liabilities	CAD 4M
WACC	13.83%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 57,216
Current liabilities	CAD 4M
Current ratio	0.01
Net working capital	CAD -1.3M
Quick ratio	0.01
Working capital	CAD -4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.75%
Shareholder yield	-3.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	112.2%
10Y return CAGR	7.82%
10Y total return	112.2%
150-day SMA	CAD 0.74
1D price change	-1.15%
1M price change	3.57%
1M total return	3.57%
1W price change	10.13%
1W total return	10.13%
1Y price change	-11.22%
1Y return CAGR	-11.23%
1Y total return	-11.22%
20-day SMA	CAD 0.85
200-day SMA	CAD 0.79
3Y price change	-19.44%
3Y return CAGR	-6.95%
3Y total return	-19.44%
50-day SMA	CAD 0.93
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 1.45
52-week high date	2026-01-12
52-week low	CAD 0.39
52-week low date	2026-05-07
5Y price change	-68.59%
5Y return CAGR	-20.68%
5Y total return	-68.59%
6M price change	83.16%
6M total return	83.16%
All-time high	CAD 5.30
All-time high date	2021-12-01
All-time low	CAD 0.20
All-time low date	2015-07-15
Average true range (ATR)	CAD 0.06
Average volume	29.1K
Beta (5Y)	1.8
Change from 52-week high	-40.69%
Change from 52-week low	120.51%
Change from all-time high	-83.58%
Change from all-time low	335%
Change from open	-1.15%
Day's gap	0%
Dollar volume	CAD 6,022
High price	CAD 0.88
Low price	CAD 0.86
Monthly RSI	42
Open price	CAD 0.87
Position in 52-week range	0%
Previous close	CAD 0.87
Price vs 150-day SMA	17.76%
Price vs 20-day SMA	1.99%
Price vs 200-day SMA	9.89%
Price vs 50-day SMA	-5.99%
Relative volume	0.24
RSI	50.13
Sharpe ratio	0.29
Sharpe ratio (3Y)	0.15
Sharpe ratio (5Y)	-0.14
Sortino ratio	0.52
Sortino ratio (3Y)	0.32
Sortino ratio (5Y)	-0.11
Volume	7K
Weekly RSI	49.88
YTD price change	-28.69%
YTD total return	-28.69%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	53.7M
Shares change (QoQ)	1.48%
Shares change (YoY)	3.75%
Shares held by insiders	20.91%

Deeper analysis on TSXV/ARCH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/ARCH report

Is a complete TSXV/ARCH research report available?

No complete published report is available for tsxv/ARCH (TSXV/ARCH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/ARCH (TSXV/ARCH)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/ARCH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/ARCH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/ARCH

Frequently asked questions